Trials / Sponsors / Brain and Cognition Discovery Foundation
Brain and Cognition Discovery Foundation
Academic / Other · 8 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Psilocybin for Treatment-Resistant Depression Treatment Resistant Depression | Phase 2 | 2021-11-19 |
| Completed | Vortioxetine for Post-COVID-19 Condition Post-COVID-19 Condition, Post-COVID-19 Syndrome, Cognitive Impairment | Phase 2 | 2021-09-16 |
| Completed | Pharmacogenetics Associated With IV Ketamine Treatment Resistant Depression | — | 2021-01-21 |
| Completed | Chart Review of Patients Undergoing Ketamine Infusions Major Depressive Disorder, Bipolar Disorder, Obsessive-Compulsive Disorder | — | 2019-12-03 |
| Completed | Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity Anhedonia, Obesity | — | 2019-10-30 |
| Completed | Validation Study: Mobile DSST on Cognition in Adults With MDD Major Depressive Episode | N/A | 2019-08-25 |
| Completed | THINC-it Vortioxetine - Sensitivity to Change Major Depressive Disorder, Cognitive Change | Phase 2 / Phase 3 | 2017-05-24 |
| Completed | Validation of the THINC-it Tool for Cognitive Dysfunction in Major Depressive Disorder Major Depressive Disorder | — | 2015-11-01 |